40340-39-4 Usage
Uses
Used in Organic Synthesis:
(3-methylisoxazol-5-yl)methyl 4-methylbenzenesulfonate is used as a reagent in organic synthesis for the preparation of various chemical compounds. Its unique structure allows it to participate in a range of chemical reactions, making it a versatile component in the synthesis of new molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (3-methylisoxazol-5-yl)methyl 4-methylbenzenesulfonate serves as an intermediate in the development of new pharmaceuticals. Its distinct chemical properties can be leveraged to create novel drug candidates with potential therapeutic applications.
Used in Drug Development:
Due to its unique chemical structure and properties, (3-methylisoxazol-5-yl)methyl 4-methylbenzenesulfonate has the potential to be used in the development of new pharmaceuticals. Further research and testing are necessary to fully understand its potential applications and properties, which could lead to the creation of innovative treatments for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 40340-39-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,3,4 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 40340-39:
(7*4)+(6*0)+(5*3)+(4*4)+(3*0)+(2*3)+(1*9)=74
74 % 10 = 4
So 40340-39-4 is a valid CAS Registry Number.
40340-39-4Relevant academic research and scientific papers
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
-
Paragraph 00198, (2015/01/16)
Disclosed are compounds of formula (I): or a pharmaceutically acceptable salt thereof; wherein Y, Ra, Ra', Rc, Rf, X2, Rd, Rd', Re, Re', m, and G have the values described herein and stereochemical configurations depicted at asterisked positions indicate absolute stereochemistry, useful as inhibitors of Sumo Activating Enzyme (SAE). Further provided are pharmaceutical compositions comprising a compound of the disclosure and methods of using the compositions in the treatment of proliferative, inflammatory, cardiovascular and neurodegenerative diseases or disorders.
